Peptides for flu season: what the science actually supports

What did @pe4power1 actually say?

The creator promoted thymosin alpha-1 (TA-1) as a research compound worth discussing during flu season. They claimed it is "naturally occurring" and derived from the thymus gland, that it can "enhance T cells," promote and also reduce inflammation, improve vaccine responses, help manage autoimmune conditions, and reduce severity of COVID-19. They were careful to frame everything with "studies suggest" and "potentially," and they did include a standard disclaimer about this not being medical advice. The video ends with affiliate discount codes for three peptide vendors.

To their credit, they did not claim TA-1 cures the flu or COVID. The hedging language was consistent throughout. That said, the video is clearly oriented toward selling product access, not neutral science communication.

Does the science back this up?

Partially, yes, but the research base is narrower and messier than this video implies. Thymosin alpha-1 is a real compound with a legitimate clinical history, which sets it apart from a lot of peptides promoted on TikTok.

TA-1, developed from thymosin fraction 5 in the 1970s by Allan Goldstein, is the active ingredient in Zadaxin, an approved drug in several countries for hepatitis B, hepatitis C, and as a vaccine adjuvant. That matters. This is not a purely theoretical compound. However, Zadaxin is not FDA-approved in the United States, and what vendors sell as "research TA-1" is not the same product that ran through those clinical trials.

On T-cell enhancement, there is real evidence. A study by Moody et al. (2002, Cancer Immunology Immunotherapy) showed TA-1 increased T-cell activity in immunocompromised cancer patients. Garaci et al. (2012, Annals of the New York Academy of Sciences) reviewed decades of research showing TA-1 modulates both innate and adaptive immunity. On COVID specifically, a randomized trial by Liu et al. (2020, Journal of Infection) found TA-1 reduced mortality in severe COVID-19 patients, though the sample size was modest and the study was conducted in China using pharmaceutical-grade Zadaxin.

The inflammation claim is where things get complicated. TA-1 appears to have context-dependent effects. It can promote pro-inflammatory cytokines when immune response is suppressed, and reduce inflammation when the immune system is overactive. Presenting this as two separate benefits without explaining the paradox, as this video does, is an oversimplification that could mislead viewers.

What did they get wrong (or right)?

They got the basic biology mostly right. The thymus gland does regulate immune development. TA-1 is genuinely derived from thymosin proteins. T cells are genuinely involved in fighting bacterial and viral infections. These are not controversial statements.

Where the video stumbles is the inflammation framing. Saying TA-1 can "promote pro-inflammatory cytokines" and also "regulate and reduce inflammation" in the same sentence, without explaining that these are context-dependent effects, is misleading. Someone watching this during flu season might think they can dial inflammation up or down on demand. That is not how this works.

The claim that TA-1 could "enhance the effects of different types of vaccines" is supported by some evidence, but only for pharmaceutical-grade TA-1 administered alongside specific vaccines in clinical settings. Implying that buying peptide powder from a vendor and self-administering it will boost your flu shot response is a significant leap from that literature.

The phrase "reduce the outcome of that nasty thing that happened back in 2020" is doing a lot of work for very limited evidence. The Liu et al. COVID trial was encouraging, but one modest RCT does not make this a proven COVID treatment. The creator stops short of saying it outright, but the implication is clear and the evidence does not yet support it.

What should you actually know?

TA-1 is one of the more research-backed peptides in the immunomodulation space, but the gap between clinical evidence and what you can actually buy from a research chemical vendor is significant. Zadaxin, the pharmaceutical version, has been through real regulatory scrutiny in some countries. The TA-1 sold by the vendors promoted in this video has not.

Purity, dosing, and sterility of research peptides from online vendors are unverified by any regulatory body. You are not getting Zadaxin. You are getting a substance that may or may not match its label, produced under unknown manufacturing conditions.

Self-treating flu symptoms, or attempting to preemptively boost your immune system with an unregulated injectable compound, based on a TikTok video during flu season is a risk profile most people should think hard about. If TA-1's clinical profile genuinely interests you, that is a conversation to have with an actual physician who works with peptide therapies, not a decision to make based on a 7,100-view TikTok with affiliate codes in the caption.

• TA-1 is not FDA-approved in the United States in any form.
• The clinical trials cited in existing research used pharmaceutical-grade Zadaxin, not research peptides.
• The affiliate codes in this video represent a direct financial incentive that viewers should factor into how they weigh this information.